Since diabetes is now a global epidemic, the incidence of retinopathy, a leading cause of
blindness in patients aged 20–74 years, is also expected to rise to alarming levels. The risk …

Many eye diseases, such as diabetic retinopathy (DR), age-related macular degeneration
(AMD), and cataracts are preventable and treatable with lifestyle. The objective of this review …

Diabetes mellitus is a chronic metabolic disorder with increasing prevalence and long-term
complications. The aim of this study was to identify α-glucosidase inhibitory compounds with …

Purpose: A growing body of evidence points to complement dysregulation in diabetes. Early
studies have indicated the presence of complement components inside the eye in patients …

Diabetic Retinopathy is a global health problem, influences 100 million individuals
worldwide, and in the next few decades, these incidences are expected to reach epidemic …

Tyrosine kinase inhibitors (TKIs) can inhibit edema and neovascularization, such as in age-
related macular degeneration and diabetic retinopathy. However, their topical administration …

Aldose reductase (ALR2) activation in the polyol pathway has been implicated as the
primary mechanism for the progression of diabetic retinopathy. Most of the aldose reductase …

The main problem both in type 1 (T1DM) and type 2 (T2DM) diabetes is the development of
chronic vascular complications encompassing micro‐as well as macrocirculation. Chronic …

Background In the context of population aging, visual impairment has emerged as a growing
concern in public health. However, there is a need for further research into the relationship …

Aim Young onset type 2 diabetes patients (T2DM-Y) have been shown to possess an
increased risk of developing microvascular complications particularly diabetic retinopathy …